Desenvolvimento de método analítico por CLAE em comprimidos de Benznidazol para a Doença de Chagas Development of an hplc analytical method for benznidazol tablets for the treatment of chagas disease

Desenvolvimento de método analítico por CLAE em comprimidos de Benznidazol para a Doença de Chagas Development of an hplc analytical method for benznidazol tablets for the treatment of chagas disease

<abstract language="eng">The analytical method of high performance liquid chromatography (HPLC) for the assay of benznidazole in tablets was developed and validated following the requirements of regulatory agencies. The method used as mobile phase acetonitrile:wather 1:1, a C18 colum...

Full description

Bibliographic Details
Main Authors:	Ana Luiza Maurer da Silva, José Lamartine Soares Sobrinho, Pedro José Rolim Neto, Rosali Maria Ferreira da Silva, Flávia Patrícia Morais de Medeiros, Leduar Guedes de Lima
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Química 2007-10-01
Series:	Química Nova
Subjects:	development of method validation high performance liquid chromatography
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422007000500021

Similar Items

Benznidazole
by: Bruno Dacunha-Marinho, et al.
Published: (2008-03-01)

From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease
by: Daniele Cavalcante Gomes, et al.
Published: (2023-09-01)

Hepatic changes by benznidazole in a specific treatment for Chagas disease.
by: Tycha Bianca Sabaini Pavan, et al.
Published: (2018-01-01)

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs
by: Eleonora Lima Alves Cunha, et al.
Published: (2019-01-01)

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
by: Miriam Rolon, et al.
Published: (2022-08-01)

Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
by: Cristina Vázquez, et al.
Published: (2023-01-01)

Access to benznidazole for Chagas disease in the United States-Cautious optimism?
by: Jonathan D Alpern, et al.
Published: (2017-09-01)

Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil
by: Maria Katarine Costa Lucas Gontijo, et al.
Published: (2020-01-01)

Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease.
by: Abilio Augusto Fragata-Filho, et al.
Published: (2016-03-01)

Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.
by: Renata Sesti-Costa, et al.
Published: (2014-10-01)

Evaluation of parasitemia by qPCR in patients with chronic Chagas disease treated with benznidazole
by: Bianca Sabaini Pavan Tycha, et al.
Published: (2023-01-01)

Adverse drug reactions to benznidazole in Chagas disease: management and successful desensitization
by: M, et al.
Published: (2020-08-01)

The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole.
by: Carlos Robello, et al.
Published: (2019-01-01)

Parasitemia and antibody response to benznidazole treatment in a cohort of patients with chronic Chagas disease
by: Carlos Henrique Valente Moreira, et al.
Published: (2023-09-01)

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil.
by: Ariela Mota Ferreira, et al.
Published: (2016-01-01)

Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.
by: Clareci Silva Cardoso, et al.
Published: (2018-11-01)

The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease
by: Mohamed Amin Ghobadifar, et al.
Published: (2014-10-01)

Correction: The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole.
by: Carlos Robello, et al.
Published: (2019-01-01)

Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole.
by: Kota Yoshioka, et al.
Published: (2020-06-01)

Reactivation of Chagas' disease successfully treated with benznidazole in a patient with acquired immunodeficiency syndrome
by: Sérgio de A. Nishioka, et al.
Published: (1993-09-01)

Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease.
by: Ana Yecê das Neves Pinto, et al.
Published: (2013-01-01)

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.
by: Tassiane Assíria Fontes Martins, et al.
Published: (2015-01-01)

Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment
by: Elena Aguilera, et al.

Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report
by: Valeria Rita Corrêa, et al.
Published: (2014-06-01)

Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
by: Marcela S Rial, et al.
Published: (2017-12-01)

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
by: Margoth Moreno, et al.
Published: (2010-11-01)

Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis.
by: Clara Crespillo-Andújar, et al.
Published: (2022-05-01)

Pharmacotherapeutic follow-up of patients with Chagas disease using benznidazole: drug-related problems and pharmaceutical interventions
by: João Paulo Ramalho Correia, et al.

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
by: Priscila Silva Grijó Farani, et al.
Published: (2021-07-01)

Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review
by: Cauê Benito Scarim, et al.

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment
by: Ana Lia Mazzeti, et al.
Published: (2023-04-01)

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
by: Marisa Liliana Fernández, et al.
Published: (2016-03-01)

Efficacy of the Benznidazole+Posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute Chagas
by: Luis Eduardo Echeverría, et al.

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
by: Priscila Silva Grijó Farani, et al.
Published: (2023-03-01)

Enfermedad de Chagas aguda, en un adulto tratado con benznidazol (Rochagan®) en Costa Rica
by: Víctor M. Montenegro, et al.
Published: (2004-06-01)

Enfermedad de Chagas aguda, en un adulto tratado con benznidazol (Rochagan®) en Costa Rica
by: Víctor M. Montenegro, et al.
Published: (2004-06-01)

Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components?
by: Maria Jose Morilla, et al.
Published: (2005-04-01)

Benznidazole as Prophylaxis for Chagas Disease Infection Reactivation in Heart Transplant Patients: A Case Series in Brazil
by: Joao Manoel Rossi Neto, et al.
Published: (2020-08-01)

Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease
by: Ágata C. Cevey, et al.
Published: (2017-12-01)

Improving the solubility of the antichagasic drug benznidazole through formation of inclusion complexes with cyclodextrins
by: José Lamartine Soares Sobrinho, et al.
Published: (2011-09-01)